Metropolitan Life Insurance CO Kymera Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$10.97 - $26.84 $3,159 - $7,729	-288 Reduced 11.58%	2,198 $55,000
Q3 2023 Nov 14, 2023	BUY	$13.9 - $23.88 $4,892 - $8,405	352 Added 16.49%	2,486 $34,000
Q1 2023 May 15, 2023	SELL	$24.84 - $38.75 $6,110 - $9,532	-246 Reduced 10.34%	2,134 $63,000
Q4 2022 Jun 14, 2023	BUY	$19.57 - $30.92 $4,814 - $7,606	246 Added 11.53%	2,380 $59.4 Million
Q4 2022 Mar 30, 2023	BUY	$19.57 - $30.92 $1,859 - $2,937	95 Added 4.16%	2,380 $59,000
Q4 2022 Feb 15, 2023	BUY	$19.57 - $30.92 $1,859 - $2,937	95 Added 4.16%	2,380 $59,000
Q3 2022 Jun 14, 2023	BUY	$20.91 - $34.27 $3,157 - $5,174	151 Added 7.08%	2,285 $49.7 Million
Q2 2022 Jun 20, 2023	BUY	$14.13 - $42.55 $2,133 - $6,425	151 Added 7.08%	2,285 $44,000
Q1 2022 Jun 20, 2023	BUY	$35.3 - $64.68 $5,330 - $9,766	151 Added 7.08%	2,285 $96,000
Q1 2022 Mar 30, 2023	SELL	$35.3 - $64.68 $246,429 - $451,531	-6,981 Reduced 75.34%	2,285 $96,000
Q1 2022 May 12, 2022	SELL	$35.3 - $64.68 $246,429 - $451,531	-6,981 Reduced 75.34%	2,285 $97,000
Q4 2021 Jun 21, 2023	BUY	$49.91 - $65.56 $355,958 - $467,573	7,132 Added 334.21%	9,266 $588,000
Q3 2021 Jun 21, 2023	BUY	$47.8 - $66.66 $340,909 - $475,419	7,132 Added 334.21%	9,266 $544,000
Q3 2021 Mar 30, 2023	BUY	$47.8 - $66.66 $33,651 - $46,928	704 Added 8.22%	9,266 $544,000
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $33,651 - $46,928	704 Added 8.22%	9,266 $544,000
Q2 2021 Jun 21, 2023	BUY	$31.08 - $51.95 $199,782 - $333,934	6,428 Added 301.22%	8,562 $415,000
Q2 2021 Mar 30, 2023	BUY	$31.08 - $51.95 $167,303 - $279,646	5,383 Added 169.33%	8,562 $415,000
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $266,013 - $444,640	8,559 Added 285300.0%	8,562 $415,000
Q1 2021 Jun 26, 2023	BUY	$35.64 - $85.46 $37,243 - $89,305	1,045 Added 48.97%	3,179 $124 Million
Q1 2021 May 14, 2021	SELL	$35.64 - $85.46 $113,192 - $271,420	-3,176 Reduced 99.91%	3 $124,000
Q4 2020 Jun 22, 2023	BUY	$28.07 - $87.83 $29,333 - $91,782	1,045 Added 48.97%	3,179 $197,000
Q4 2020 Mar 30, 2023	BUY	$28.07 - $87.83 $22,427 - $70,176	799 Added 33.57%	3,179 $197,000
Q4 2020 Feb 16, 2021	BUY	$28.07 - $87.83 $89,234 - $279,211	3,179 New	3,179 $197,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

Price T Rowe Associates Inc Baltimore, MD

6.65M
Shares

$279 Million
0.04% of portfolio
Baker Bros. Advisors LP New York, NY

6M
Shares

$252 Million
3.04% of portfolio
Bvf Inc San Francisco, CA

5.16M
Shares

$217 Million
7.77% of portfolio
Atlas Venture Life Science Advisors, LLC

4.9M
Shares

$205 Million
28.59% of portfolio
Vanguard Group Inc Valley Forge, PA

4.75M
Shares

$199 Million
0.0% of portfolio

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account